Skip to main content
HCPCS Q4081 · Level II · Part B drug

Q4081: epoetin alfa (Epogen, Procrit), ESRD on dialysis, HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q4081

Billing unit
100 UNITS
Epoetin alfa, 100 units esrd
ASP payment limit
$0.667
October 2026; -3.1% vs July 2026
Practitioner MUE
100
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
4
15 states

TL;DR

HCPCS Q4081 is the Level II code for Injection, epoetin alfa, 100 units (for esrd on dialysis), billed per 100 UNITS. The Medicare Part B ASP payment limit for October 2026 is $0.667 per billing unit, down 3.1% from July 2026. The practitioner MUE allows up to 100 units per date of service (MAI 3), so a full 100-unit day is $66.70 at the current limit. Under OPPS it carries status indicator N. Because the descriptor is specific to ESRD patients on dialysis, Medicare expects the drug inside the ESRD prospective payment bundle when furnished by the dialysis facility, and separate Part B billing applies only outside that setting. Other HCPCS codes whose descriptor names epoetin alfa: Q5106 (for non-ESRD use; biosimilar epoetin alfa-epbx (Retacrit); billed per 1000 units); J0885 (for non-ESRD use; billed per 1000 units); Q5105 (biosimilar epoetin alfa-epbx (Retacrit)). The ASP crosswalk maps 18 NDCs to it, sold as Epogen, Procrit by Amgen Inc, Janssen Products, LP. 4 Medicare coverage articles list the code across 15 states, including A56462.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for Q4081 at $0.667 per 100 UNITS for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.688 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for Q4081
QuarterPayment limitPerCoinsurance
October 2026$0.667100 UNITS20%
July 2026$0.688100 UNITS—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 18 NDCs from 2 labelers to Q4081. Report the NDC in the claim's drug segment and bill the number of Q4081 units that equals the quantity administered divided by 100 UNITS; the last column gives units per full package.

NDCs that crosswalk to Q4081
NDCDrug nameLabelerPackage sizeBilling units / package
55513-0126-10EpogenAmgen Inc1 × 10200
55513-0126-20EpogenAmgen Inc1 × 10200
55513-0144-10EpogenAmgen Inc1 × 101000
55513-0148-10EpogenAmgen Inc1 × 10400
55513-0267-10EpogenAmgen Inc1 × 10300
55513-0267-20EpogenAmgen Inc1 × 10300
55513-0283-10EpogenAmgen Inc2 × 102000
55513-0283-20EpogenAmgen Inc2 × 102000
55513-0478-10EpogenAmgen Inc1 × 102000
55513-0478-20EpogenAmgen Inc1 × 102000
59676-0302-01ProcritJanssen Products, LP1 × 6120
59676-0303-01ProcritJanssen Products, LP1 × 6180
59676-0304-01ProcritJanssen Products, LP1 × 6240
59676-0310-01ProcritJanssen Products, LP1 × 6600
59676-0310-02ProcritJanssen Products, LP1 × 252500
59676-0312-04ProcritJanssen Products, LP2 × 4800
59676-0320-04ProcritJanssen Products, LP1 × 4800
59676-0340-01ProcritJanssen Products, LP1 × 41600

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q4081. For practitioners the limit is 100 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q4081 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1003 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital4003 Date of Service Edit: ClinicalClinical: Data

MUE for Q4081 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for Q4081 is 200 units for practitioner claims (Medicare: 100). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q4081 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q4081 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q4081 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

4 current Medicare Administrative Contractor articles list Q4081 in their HCPCS tables, covering 15 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing Q4081
ArticleTitleContractor(s)StatesRelated LCD
A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)CGS Administrators, LLCKY OHL34356
A56795Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)Wisconsin Physicians Service Insurance CorporationIA KS MO NEL34633, L38446
A58982Billing and Coding: Erythropoiesis Stimulating AgentsPalmetto GBANC SC VA WVL39237
A60381Billing and Coding: Erythropoiesis Stimulating AgentsWellpoint FederalCT IL MN NY WIL40334

Diagnoses Medicare contractors cover for Q4081

4 billing and coding articles attach a covered diagnosis list to Q4081: 1,253 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for Q4081
ICD-10-CMDescription (FY2027)Articles covering
D63.1Anemia in chronic kidney disease4 of 4
N18.6End stage renal disease4 of 4
I12.0Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease1 of 4
I12.9Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease1 of 4
I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease1 of 4
I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease1 of 4
I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease1 of 4
I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease1 of 4
N18.30Chronic kidney disease, stage 3 unspecified1 of 4
N18.31Chronic kidney disease, stage 3a1 of 4
N18.32Chronic kidney disease, stage 3b1 of 4
N18.4Chronic kidney disease, stage 4 (severe)1 of 4
N18.5Chronic kidney disease, stage 51 of 4
B20Human immunodeficiency virus [HIV] disease1 of 4
B97.35Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere1 of 4
1,238 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to Q4081 are counted here: a group whose instructions name Q4081, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to Q4081, by article
ArticleContractorGroups that applyCovered codes for Q4081Full list
A56462CGS Administrators, LLCone list for every code in the article1,253On LCD L34356
A56795Wisconsin Physicians Service Insurance Corporationgroup 1 applies to Q40812On LCD L34633
A58982Palmetto GBAgroup 1 applies to Q40812On LCD L39237
A60381Wellpoint Federalgroup 1 applies to Q40812On LCD L40334

Local coverage policies that list Q4081

4 active Local Coverage Determinations list Q4081 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

  • LCD L39237: Erythropoiesis Stimulating Agents · Palmetto GBA
  • L34356 Erythropoiesis Stimulating Agents (ESA) · CGS Administrators, LLC
  • L34633 Erythropoiesis Stimulating Agents (ESAs) · Wisconsin Physicians Service Insurance Corporation
  • L40334 Erythropoiesis Stimulating Agents · Wellpoint Federal

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q4081 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for Q4081 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q4081

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q4081

What does HCPCS code Q4081 describe?

Q4081 is defined by CMS as "Injection, epoetin alfa, 100 units (for esrd on dialysis)". Each billing unit represents 100 UNITS, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q4081 a CPT code?

No. Q4081 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as epoetin alfa; CPT codes are five-character codes maintained by the AMA. On a Part B claim Q4081 reports the drug itself in 100 units units, and the administration is billed on its own line.

What is the Medicare reimbursement for Q4081 in October 2026?

The ASP-based payment limit is $0.667 per 100 UNITS, with 20% beneficiary coinsurance. The July 2026 limit was $0.688. Commercial payers use their own fee schedules.

How many units of Q4081 can be billed per day?

The practitioner Medically Unlikely Edit is 100 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 400. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to Q4081?

The October 2026 ASP crosswalk lists 18 NDCs from 2 labelers: Epogen (Amgen Inc); Procrit (Janssen Products, LP). For example NDC 55513-0126-10 (package size 1) equals 200 billing units of Q4081.

Does Q4081 have NCCI bundling edits?

No active practitioner PTP pairs list Q4081 as a column-1 or column-2 code in the v323r0 release.

Q4081 vs Q5106: what is the difference?

Both are HCPCS Level II codes whose descriptor names epoetin alfa. What sets Q5106 apart: for non-ESRD use; biosimilar epoetin alfa-epbx (Retacrit); billed per 1000 units. Q4081 is billed per 100 units, limit $0.667, MUE 100; Q5106 is billed per 1000 units, limit $8.171, MUE 60. Report the code whose descriptor matches the product and setting in the record.

Q4081 vs J0885: what is the difference?

Both are HCPCS Level II codes whose descriptor names epoetin alfa. What sets J0885 apart: for non-ESRD use; billed per 1000 units. Q4081 is billed per 100 units, limit $0.667, MUE 100; J0885 is billed per 1000 units, limit $6.669, MUE 60. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention Q4081?

4 current Billing and Coding Articles in the Medicare Coverage Database list Q4081, covering 15 states: A56462 (Billing and Coding: Erythropoiesis Stimulating Agents (ESA)); A56795 (Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)); A58982 (Billing and Coding: Erythropoiesis Stimulating Agents).

What diagnosis codes support Q4081?

4 Medicare billing and coding articles list 1,253 covered ICD-10-CM codes for Q4081 between them, for example D63.1 (Anemia in chronic kidney disease); N18.6 (End stage renal disease); I12.0 (Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease); I12.9 (Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease); I13.0 (Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.